Bellevue Group Ag Neuronetics, Inc. Transaction History

Bellevue Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.82 - $5.87 $455,000 - $1.47 Million	-250,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.41 - $2.61 $107,105 - $198,258	-75,961 Reduced 23.3%	250,000 $483,000
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $9,822 - $15,401	1,182 Added 0.36%	325,961 $2.71 Million
Q2 2019 Aug 14, 2019	BUY	$9.0 - $17.2 $264,978 - $506,402	29,442 Added 9.97%	324,779 $4.06 Million
Q1 2019 May 15, 2019	BUY	$13.6 - $19.58 $1.77 Million - $2.54 Million	129,937 Added 78.56%	295,337 $4.5 Million
Q4 2018 Feb 12, 2019	BUY	$16.0 - $31.84 $855,888 - $1.7 Million	53,493 Added 47.8%	165,400 $3.2 Million
Q3 2018 Nov 13, 2018	BUY	$24.32 - $37.54 $1.51 Million - $2.32 Million	61,907 Added 123.81%	111,907 $3.59 Million
Q2 2018 Aug 07, 2018	BUY	$26.61 - $27.78 $1.33 Million - $1.39 Million	50,000 New	50,000 $1.32 Million

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.